Page 1627 - Williams Hematology ( PDFDrive )

1602 Part XI: Malignant Lymphoid Diseases <CN>: <CT> PB

52. Savage KJ, Monti S, Kutok JL, et al: The molecular signature of mediastinal large B-cell 64. Sternberg C: Uber eine Eigenartige unter dem Bilde der Pseudoleukamie verlaufende
lymphoma differs from that of other diffuse large B-cell lymphomas and shares features Tuberculose des lymphatischen Apparates. Z Heilk 19:21, 1898.
with classical Hodgkin lymphoma. Blood 102:3871, 2003. 65. Reed DM: On the pathologic changes in Hodgkin’s disease, with especial reference to its
53. Dave SS, Fu K, Wright GW, et al: Molecular diagnosis of Burkitt’s lymphoma. N Engl J relation to tuberculosis. Johns Hopkins Hosp Rep 10:133, 1902.
Med 354:2431, 2006. 66. Strum SB, Park JK, Rappaport H: Observation of cells resembling Sternberg-Reed cells
54. Hummel M, Bentink S, Berger H, et al: A biologic definition of Burkitt’s lymphoma in conditions other than Hodgkin’s disease. Cancer 26:176, 1970.
from transcriptional and genomic profiling. N Engl J Med 354:2419, 2006. 67. Harris NL: Hodgkin’s disease: Classification and differential diagnosis. Mod Pathol 12:
55. Iqbal J, Wright G, Wang C, et al: Gene expression signatures delineate biological and 159, 1999.
prognostic subgroups in peripheral T-cell lymphoma. Blood 123:2915, 2014. 68. Kuppers R, Rajewsky K: The origin of Hodgkin and Reed/Sternberg cells in Hodgkin’s
56. Gaulard P, de Leval L. Follicular helper T cells: implications in neoplastic hematopa- disease. Annu Rev Immunol 16:471, 1998.
thology. Semin Diagn Pathol 28:202, 2011. 69. Jarrett RF, MacKenzie J: Epstein-Barr virus and other candidate viruses in the patho-
57. Stein H, Foss HD, Durkop H, et al: CD30(+) anaplastic large cell lymphoma: A review genesis of Hodgkin’s disease. Semin Hematol 36:260, 1999.
of its histopathologic, genetic, and clinical features. Blood 96:3681, 2000. 70. Skinnider BF, Mak TW: The role of cytokines in classical Hodgkin lymphoma. Blood
58. Gascoyne RD, Aoun P, Wu D, et al: Prognostic significance of anaplastic lymphoma 99:4283, 2002.
kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 71. von Wasielewski R, Werner M, Fischer R, et al: Lymphocyte-predominant Hodgkin’s
93:3913, 1999. disease. An immunohistochemical analysis of 208 reviewed Hodgkin’s disease cases
59. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al: ALK-positive lymphoma: A from the German Hodgkin Study Group. Am J Pathol 150:793, 1997.
single disease with a broad spectrum of morphology. Blood 91:2076, 1998. 72. Anagnostopoulos I, Hansmann ML, Franssila K, et al: European Task Force on Lym-
60. Duyster J, Bai RY, Morris SW: Translocations involving anaplastic lymphoma kinase phoma project on lymphocyte predominance Hodgkin disease: Histologic and immu-
(ALK). Oncogene 20:5623, 2001. nohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a
61. Savage KJ, Harris NL, Vose JM, et al: ALK-negative anaplastic large cell lymphoma nodular growth pattern and abundant lymphocytes. Blood 96:1889, 2000.
(ALCL) is clinically and immunophenotypically different from both ALK-positive 73. Mason DY, Banks PM, Chan J, et al: Nodular lymphocyte predominance Hodgkin’s
ALCL and peripheral T cell lymphoma, not otherwise specified: Report from the Inter- disease. A distinct clinicopathological entity. Am J Surg Pathol 18:526, 1994.
national Peripheral T-cell Lymphoma Project. Blood 111:5496, 2008. 74. Chan WC: Cellular origin of nodular lymphocyte-predominant Hodgkin’s lymphoma:
62. Feldman AL, Dogan A, Smith DI, et al: Discovery of recurrent t(6;7)(p25.3;q32.3) Immunophenotypic and molecular studies. Semin Hematol 36:242, 1999.
translocations in ALK-negative anaplastic large cell lymphomas by massively parallel
genomic sequencing. Blood 117:915, 2011.
63. Vasmatzis G, Johnson SH, Knudson RA, et al: Genome-wide analysis reveals recur-
rent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell
lymphomas. Blood 120:2280, 2012.

Kaushansky_chapter 96_p1587-1602.indd 1602 9/18/15 6:08 PM